Molecure S.A.
MOC.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.14 | 0.23 | 0.18 | -0.12 |
| FCF Yield | -4.40% | -31.48% | 12.08% | -19.67% |
| EV / EBITDA | -29.99 | -36.47 | -34.38 | -20.32 |
| Quality | ||||
| ROIC | -5.76% | -3.64% | -5.20% | -9.40% |
| Gross Margin | 0.00% | 89.33% | 0.00% | 0.00% |
| Cash Conversion Ratio | 1.27 | 10.23 | -5.04 | 3.32 |
| Growth | ||||
| Revenue 3-Year CAGR | 29.40% | 40.39% | -21.11% | -20.29% |
| Free Cash Flow Growth | 81.39% | -260.22% | 155.82% | -279.92% |
| Safety | ||||
| Net Debt / EBITDA | 3.75 | 10.96 | 7.71 | 1.15 |
| Interest Coverage | -268.68 | -258.31 | -1,076.96 | -1,449.39 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -82.65 | -210.63 | -148.19 |